Seminars in Oncology Nursing最新文献

{"title":"An Exploration of Nursing Roles in Hereditary Colorectal Cancer- A Narrative Literature Review","authors":"Mechelle Loughrey ,&nbsp;Mary Forry ,&nbsp;Roberta Horgan ,&nbsp;Aisling Hegarty","doi":"10.1016/j.soncn.2025.152120","DOIUrl":"10.1016/j.soncn.2025.152120","url":null,"abstract":"<div><h3>Objectives</h3><div>Hereditary colorectal cancer (CRC) syndromes, including Lynch syndrome and the adenomatous and hamartomatous polyposis conditions, account for up to 10% of CRC cases. Advances in molecular diagnostics and tumor-based testing have improved identification, yet access to genetic testing and lifelong surveillance remains inconsistent worldwide. This narrative review examines the evolving role of nurses in identifying, managing, and supporting individuals and families affected by hereditary CRC.</div></div><div><h3>Methods</h3><div>A narrative synthesis of international literature, clinical guidelines, and examples of nurse-led models of care from Europe, the United Kingdom, Canada, the United States, Australia, and other health systems was conducted. Articles were included if they addressed hereditary CRC epidemiology, genomic workforce issues, nursing roles, service delivery, or patient experience. A narrative approach was selected to integrate policy documents, and practice models not suited to systematic review methods.</div></div><div><h3>Results</h3><div>Five themes emerged: previvorship and living with inherited risk, genomics workforce capacity, evolving nursing roles, lifelong surveillance, and genomics education. Across health systems, nurses, particularly advanced nurse practitioners (ANPs), clinical nurse specialists (CNSs), and oncology nurses, play an increasingly significant role in hereditary CRC pathways. Their contributions include family history assessment, mainstreaming genetic testing, surveillance coordination, psychosocial support, and patient navigation. Nurse-led models improve access to testing, reduce diagnostic delays, and enhance surveillance adherence. However, roles remain inconsistent across jurisdictions, and challenges persist, including workforce shortages, variable genomics education, limited funding, and an uneven evidence base across the full spectrum of hereditary CRC syndromes.</div></div><div><h3>Conclusions</h3><div>Nurses act as coordinators across gastroenterology, surgery, oncology, genetics, and primary care- supporting equitable access and continuity throughout the hereditary CRC care trajectory. Despite their growing impact, nursing roles remain under-recognized in guidelines and under-evaluated in research. Systematic investment in genomics education, structured role development, and nurse-led models is required to deliver consistent, patient-centered hereditary CRC care.</div></div><div><h3>Implications for Nursing Practice</h3><div>Embedding genomics in nursing education, strengthening structured roles, and supporting nurse-led services within multidisciplinary frameworks are essential to improving equitable access and outcomes.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"42 2","pages":"Article 152120"},"PeriodicalIF":2.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145946073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cancer Nursing Interventions for Sexual Function and Satisfaction in Men with Prostate Cancer: A Systematic Review and Meta-analysis","authors":"Canan Birimoğlu Okuyan ,&nbsp;Müjde Kerkez ,&nbsp;Aylin Bilgin","doi":"10.1016/j.soncn.2026.152169","DOIUrl":"10.1016/j.soncn.2026.152169","url":null,"abstract":"<div><h3>Objectives</h3><div>This systematic review and meta-analysis aimed to evaluate the effectiveness of interventions particularly psychoeducational and physical activity-based approaches on sexual function and satisfaction among individuals diagnosed with prostate cancer.</div></div><div><h3>Methods</h3><div>A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and CINAHL databases to identify relevant studies published between 2010 and 2023. Studies were included if they involved interventions targeting sexual health in prostate cancer patients. Data were synthesized using random-effects meta-analysis models, and the quality of included studies was assessed using standardized criteria.</div></div><div><h3>Results</h3><div>A total of 14 studies met the inclusion criteria. Meta-analytic findings indicated that psychoeducational interventions, especially when combined with physical activity or counseling, significantly improved sexual function (SMD = 0.31, 95% CI: 0.03-0.60, <em>P</em> = .03) and satisfaction (SMD = 0.27, 95% CI: 0.04-0.50, <em>P</em> = .02). These interventions demonstrated moderate heterogeneity but consistently showed beneficial outcomes.</div></div><div><h3>Conclusions</h3><div>The findings support the integration of nurse-led psychoeducational and behavioral interventions into routine care for prostate cancer patients. Such approaches can enhance patients’ sexual well-being, quality of life, and psychological resilience during survivorship.</div></div><div><h3>Implications for Nursing Practice</h3><div>Oncology nurses play a pivotal role in delivering holistic care to prostate cancer patients. Incorporating structured sexual health counseling, exercise-based rehabilitation, and psychoeducational support into survivorship programs can significantly improve sexual outcomes. This evidence reinforces the need for oncology nursing practices that prioritize sexual health as a key component of quality cancer care. These findings support integrating structured nurse-led sexual health interventions into survivorship care and highlight sexual wellbeing as a core component of holistic oncology nursing.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"42 2","pages":"Article 152169"},"PeriodicalIF":2.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147322251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inequalities in Genetic Services for Hereditary Breast and Ovarian Cancer: A Bibliometric and Thematic Analysis","authors":"Eda Sahin ,&nbsp;Merve Oksuz ,&nbsp;Cagla Yigitbas","doi":"10.1016/j.soncn.2026.152170","DOIUrl":"10.1016/j.soncn.2026.152170","url":null,"abstract":"<div><h3>Objectives</h3><div>This review aimed to examine the inequalities in access to genetic counseling and testing services among individuals with Hereditary Breast and Ovarian Cancer Syndrome (HBOC) using bibliometric and thematic analysis methods.</div></div><div><h3>Methods</h3><div>In this mixed methods study, conducted using an explanatory sequential design, 421 articles published in the Web of Science database between 1997 and 2025 were first analyzed bibliometrically. In the second stage, thematic analysis was conducted on the 10 most cited studies.</div></div><div><h3>Results</h3><div>Bibliometric findings indicate that scientific production in this field has increased significantly since 2013, with studies conducted primarily by US-based institutions and supported by strong international collaborations. Thematic analysis identified four main themes: (1) inequities in access to and participation in services, (2) differences in clinical outcomes, (3) changes in service delivery models, and (4) communication barriers. Findings revealed that inequities in access to genetic services under HBOC are related not only to individual awareness or economic status but also to systemic and cultural factors. Furthermore, remote (telephone) genetic counseling has been shown to have the potential to reduce geographic and structural barriers.</div></div><div><h3>Conclusions</h3><div>Consequently, culturally tailored, accessible, and multidisciplinary approaches to addressing health disparities in HBOC are needed. Future research is recommended to compare experiences across countries using multiple data sources.</div></div><div><h3>Implications for Nursing Practice</h3><div>This study demonstrates that nurses play a crucial role in facilitating access to genetic counseling and testing services for individuals at risk for hereditary cancer. Strengthening nurses' genetic literacy, cultural sensitivity, and equity-based care approaches will increase service accessibility and the effectiveness of holistic care.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"42 2","pages":"Article 152170"},"PeriodicalIF":2.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147328244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Educating Nurses for Genomics-Informed Cancer Care: Strengthening the Current and Future Workforce","authors":"Patricia Friend ,&nbsp;Suzanne M. Mahon ,&nbsp;Kathleen Calzone","doi":"10.1016/j.soncn.2026.152168","DOIUrl":"10.1016/j.soncn.2026.152168","url":null,"abstract":"<div><h3>Objectives</h3><div>To examine the educational and practice gaps that limit genomic competency among oncology nurses and to propose strategies to strengthen workforce preparedness. Genomically informed cancer care has redefined oncology practice by enabling precision prevention, diagnosis, and treatment through germline and somatic biomarker testing. However, the oncology nursing workforce remains insufficiently prepared to deliver this care safely and effectively.</div></div><div><h3>Methods</h3><div>A review of peer-reviewed literature.</div></div><div><h3>Results</h3><div>Based on the literature review, despite more than two decades of national initiatives to integrate genomics into nursing education, genomic content remains inconsistently embedded in both prelicensure and graduate curricula. Faculty often report limited readiness to teach this rapidly evolving science, while licensure and certification examinations rarely assess genomic competencies, perpetuating its de-emphasis in nursing curricula.</div></div><div><h3>Conclusions</h3><div>Oncology nurses may misinterpret germline biomarker results, misunderstand inheritance patterns, or overlook opportunities for cascade testing, compromising both individual treatment and family risk reduction. Given their pivotal role in patient and family communication, oncology nurses must develop genomic literacy that supports a family-centered model of care for hereditary cancer syndromes.</div></div><div><h3>Implications for Nursing Practice</h3><div>Strengthening genomic competency across the oncology nursing continuum requires deliberate competency-based curricula, sustained faculty development, and national efforts to realign educational and regulatory frameworks to support the safe, evidence-based, and family-centered delivery of genomically informed cancer care.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"42 2","pages":"Article 152168"},"PeriodicalIF":2.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147437778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Genomic Instability in Hereditary Breast Cancer: Clinical and Nursing Implications for Risk Assessment and Targeted Therapeutic Strategies","authors":"Aladeen Alloubani ,&nbsp;Refat Nimer ,&nbsp;Fatima Farhan ,&nbsp;Farah Eid ,&nbsp;Yahya Khawaja","doi":"10.1016/j.soncn.2025.152054","DOIUrl":"10.1016/j.soncn.2025.152054","url":null,"abstract":"<div><h3>Objectives</h3><div>This review aims to bridge genomic insights with oncology nursing practice, promoting risk-informed care for patients with hereditary breast cancer (HBC).</div></div><div><h3>Methods</h3><div>This study reviewed publications from 2018 to 2024, searching PubMed, CINAHL, and Cochrane under PRISMA guidelines. It systematically reviews GI, emphasizing sporadic and hereditary breast cancer (BC), including BRCA1/2-related hereditary breast and ovarian cancer syndrome (HBOC), Li-Fraumeni syndrome (TP53 mutations), and Lynch syndrome (MSI-driven BC).</div></div><div><h3>Results</h3><div>Key genomic alterations such as TP53, BRCA1/2, and BCL2 mutations were found across various BC subtypes, including triple-negative, HER2-positive, and hormone receptor-positive tumors. Given the hereditary nature of some BC cases, genetic testing is crucial for risk assessment and early intervention, particularly as part of personalized screening protocols.</div><div>Inhibiting these pathways with BCL2 inhibitors, PARP inhibitors for BRCA-mutated tumors, and immune checkpoint inhibitors for MSI-high tumors represents a promising therapeutic strategy.</div></div><div><h3>Conclusions</h3><div>This review highlights the importance of integrating genomic findings into personalized care planning, genetic counseling, and patient education.</div></div><div><h3>Implications for Nursing Practice</h3><div>Oncology nurses play a central role in applying genomic knowledge in patient care. They support informed decision-making regarding genetic testing, encourage adherence to surveillance protocols, monitor patients on targeted therapies, and advocate for equitable access to genetic services.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"42 2","pages":"Article 152054"},"PeriodicalIF":2.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Family Caring, Culture, and Communication: Barriers to BRCA-Related Risk Disclosure in Korea—A Qualitative Study","authors":"Juhye Jin ,&nbsp;Jeehee Han ,&nbsp;Soo Yeon Kim ,&nbsp;Maria C. Katapodi ,&nbsp;Sue Kim","doi":"10.1016/j.soncn.2026.152146","DOIUrl":"10.1016/j.soncn.2026.152146","url":null,"abstract":"<div><h3>Objectives</h3><div>Despite the importance of disclosing a pathogenic/likely pathogenic (P/LP) variant related to hereditary cancer, fewer than half of index cases share their genetic test results with at-risk, biological relatives. Given this missed opportunity for cancer prevention, this study explored the barriers to family communication in Korea, from the perspective of women with hereditary breast and ovarian cancer syndrome.</div></div><div><h3>Methods</h3><div>In-depth interviews were conducted with 22 women (17 affected, 5 unaffected) carrying P/LP variants in one the <em>BRCA</em> genes in Korea. Individual face-to-face and small-group interviews were conducted between August 2020 and November 2021. Narrative data were analyzed using inductive content analysis to identify how participants experienced and interpreted barriers to family communication.</div></div><div><h3>Results</h3><div>Participants expressed a need for more information and guidance before initiating conversations with relatives. Emotional burden was especially heightened for affected carriers, who had to manage their own cancer diagnosis while assuming the responsibility of informing relatives. Four key barriers to family communication were identified: (1) Blurry understanding of <em>BRCA</em> in social and health context; (2) emotional turmoil in clinical communication; (3) disrupted expectations in family risk communication; and (4) culturally shaped disclosure decisions.</div></div><div><h3>Conclusions</h3><div>Women with P/LP variants in <em>BRCA</em> genes face multifaceted barriers in communicating hereditary cancer risk to their relatives. Disclosure should be framed not as delivering bad news but as conveying actionable and preventive information. Culturally sensitive, stepwise communication support, delivered consistently by healthcare professionals, is needed to help carriers navigate this process and avoid isolation and emotional distress.</div></div><div><h3>Implications for Nursing Practice</h3><div>Nurses are critical mediators in the physician-patient-family nexus, playing a role that extends beyond clinical support to include emotional guidance, risk communication, and cultural sensitivity in facilitating family communication.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"42 2","pages":"Article 152146"},"PeriodicalIF":2.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146159144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of Digital Tools on Knowledge, Genetic Counseling, and Testing Uptake: A Systematic Review and Meta-analysis","authors":"Maide Nur Tümkaya ,&nbsp;Şeyma İnciser Paşalak ,&nbsp;Memnun Seven","doi":"10.1016/j.soncn.2026.152144","DOIUrl":"10.1016/j.soncn.2026.152144","url":null,"abstract":"<div><h3>Objectives</h3><div>This systematic review and meta-analysis aimed to synthesize evidence on the effects of digital genetic tools on completion of pretest counseling, uptake of genetic testing, and knowledge.</div></div><div><h3>Methods</h3><div>The meta-analysis was performed using Review Manager (RevMan 5.4.1) software to synthesize effect sizes. Databases including, PubMed, Web of Science, Ovid MEDLINE, CINAHL, and Scopus were searched. The methodological quality of the studies was assessed using the Cochrane and Joanna Briggs Institute (JBI) critical appraisal checklists.</div></div><div><h3>Results</h3><div>Seventeen studies with 6,714 participants were included. Digital interventions significantly increased completion of pretest counseling across four studies (Odds ratio [OR] 2.07, 95% confidence interval [95% CI] 1.22-3.51; Z = 2.70, <em>P</em> = .0007). Genetic testing uptake did not differ between digital and in-person care across seven studies (OR 1.30, 95% CI 0.80-2.10; <em>P</em> = .29; I² = 82%). Knowledge outcomes were comparable for telehealth versus in-person (SMD −0.09, 95% CI −0.40 to 0.23; <em>P</em> = .59); other digital formats suggested greater gains in some settings (SMD 1.19, 95% CI 0.01-2.37; <em>P</em> = .05), though pooled effects were not statistically significant and heterogeneity was substantial.</div></div><div><h3>Conclusions</h3><div>Digital tools are generally noninferior to in-person care for knowledge and psychosocial outcomes and roughly equivalent for genetic test uptake, while doubling the odds of completing pretest counseling.</div></div><div><h3>Implications for nursing practice</h3><div>Digital genetic counseling delivered via telehealth, web-based platforms, and AI-supported tools can expand access to genetic services while maintaining patient-centered care. Nurses play a key role in guiding patients through these technologies and supporting informed, equitable access within digital and hybrid care models.</div><div>Registration: PROSPERO (CRD420251042666)</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"42 2","pages":"Article 152144"},"PeriodicalIF":2.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146196046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quality and Safety Imperatives in the Identification and Management of Hereditary Cancer Syndromes","authors":"Kathleen Calzone ,&nbsp;Suzanne M. Mahon ,&nbsp;Patricia Friend","doi":"10.1016/j.soncn.2026.152174","DOIUrl":"10.1016/j.soncn.2026.152174","url":null,"abstract":"<div><h3>Objectives</h3><div>We sought to provide an evidence review of the rapidly expanding technologies and sciences that have moved the field of hereditary cancers from niche to mainstream in current cancer care. This shift mandates that all oncology clinicians have foundational knowledge regarding the identification, testing, and management of patients and families at risk for hereditary cancer. Many cancers have established germline biomarker testing recommendations (breast, ovarian, pancreatic, metastatic prostate, colon), and in many of these cancer types, somatic biomarker tests are also considered standard of care. Unfamiliarity with the complexity of care in hereditary cancer leads to missed opportunities for cancer prevention and guideline-concordant genomic-informed care. Indeed, appropriately ordered, interpreted, and applied germline biomarker testing is a critical quality care indicator. Moreover, preventing harm from overlooked or inappropriate germline biomarker testing and incorrect result interpretation leads to optimal cancer prevention and effective cancer treatment. This is a central safety aspect in this rapidly changing landscape.</div></div><div><h3>Methods</h3><div>A review of peer-reviewed literature.</div></div><div><h3>Results</h3><div>Based on the literature review, the Five Rights of Germline Biomarker Testing for Hereditary Cancer is offered as a quality and safety framework. Accurate construction and interpretation of the pedigree continue to be a critical risk assessment tool. A comprehensive view of patient factors, family history, tumor pathology, and somatic biomarker test results is essential for quality care in hereditary cancers.</div></div><div><h3>Conclusion</h3><div>Oncology clinicians must be familiar with and refer to the most recent and updated versions of guidelines from reputable authorities, as the testing criteria shift frequently.</div></div><div><h3>Implications for Nursing Practice</h3><div>The five rights framework offers clinicians a guide to safe practice in this ever-changing landscape.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"42 2","pages":"Article 152174"},"PeriodicalIF":2.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Facilitators and Barriers to Prognostic Communication among Oncology Nurses in Low and Middle-Income Countries: A Scoping Review.","authors":"Joshua Kanaabi Muliira, Gerald Amandu Matua, Asma Al Yahyaei, Prossy Nandawula, Eilean Rathinasamy Lazarus","doi":"10.1016/j.soncn.2026.152208","DOIUrl":"https://doi.org/10.1016/j.soncn.2026.152208","url":null,"abstract":"<p><strong>Objective: </strong>This scoping review aimed to identify the barriers and facilitators of prognostic communication experienced by oncology nurses in low and middle-income countries (LMICs).</p><p><strong>Methods: </strong>A scoping review was conducted using Arksey and O'Malley's framework. Searches of MEDLINE, Scopus, Embase, CINAHL, and ScienceDirect (2015-2025), plus grey literature, identified empirical studies focusing on oncology nurses' prognostic communication in LMICs. Two reviewers independently screened the articles and charted the data. The findings were synthesized thematically using line-by-line coding (Registered in PROSPERO: CRD420251239353).</p><p><strong>Results: </strong>From 1,784 records, nine studies met the inclusion criteria, most were qualitative (6), and the others were a mixed methods (1) and quantitative cross-sectional (2) studies. The review identified and classified barriers and facilitators to prognostic communication into three categories: (1) health system and environmental factors, (2) nurse-related factors, and (3) patient and family-related factors. The facilitators were also summarized into three categories of health system/environment, nurse, and patient and family facilitators.</p><p><strong>Conclusion: </strong>Multiple barriers and facilitators influence prognostic communication among oncology nurses in LMICs. However, some of the health system/environmental and nurse-related factors are amenable to improvement using nurse-led interventions designed to strengthen nurses' competencies in prognostic communication.</p><p><strong>Implications for nursing practice: </strong>Strengthening oncology nurses' prognostic communication competencies is essential because it ensures patient-centered care, patient safety, and ethical safeguards. Thus, providing training in prognostic communication enhances clinical expertise and effectiveness, and may promote safer, more effective oncology nursing care.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"152208"},"PeriodicalIF":2.3,"publicationDate":"2026-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147596168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What We Need to Know About Cancer Immunotherapy: A Qualitative Study of Patient, Family and Healthcare Professional Preferences for Written, Visual and Animated Information.","authors":"Camilla Skov Rothausen, Nina Ingerslev Andersen, Lærke Kjær Tolstrup, Christina Halgaard Bruvik Ruhlmann, Helle Pappot, Rebekah Laidsaar-Powell, Karin Brochstedt Dieperink","doi":"10.1016/j.soncn.2026.152207","DOIUrl":"https://doi.org/10.1016/j.soncn.2026.152207","url":null,"abstract":"<p><strong>Objectives: </strong>This study explored the educational needs, preferences and preferred formats of patients with cancer, their caregivers, and healthcare professionals regarding immune checkpoint inhibitor (ICI) therapy with attention to varying levels of health literacy.</p><p><strong>Methods: </strong>A qualitative hermeneutic design was applied. Semi-structured interviews were conducted with patients receiving ICI therapy and their caregivers: six dyadic and eight individual interviews. A focus group with healthcare professionals complemented the interview data. Data collection took place from September to December 2024. Data were analysed collectively using systematic text condensation.</p><p><strong>Results: </strong>Three themes were identified: (1) factors affecting perception and understanding of information, (2) core educational needs for understanding treatment with immunotherapy, and (3) preferences for educational material. Caregivers supported patients in understanding treatment-related information. Emotional distress and limited health literacy reduced the capacity to absorb and understand information. Participants emphasised preferences for simple, repeated information delivered through multicomponent educational materials combining written, visual, and audio formats.</p><p><strong>Conclusions: </strong>Caregiver support, health literacy, and emotional state influence how patients and caregiver perceive and understand information on ICI therapy. A multicomponent educational model-comprising information pathways with oncologists and nurses and using visual tools-may address diverse emotional needs and varying levels of health literacy and caregiver support.</p><p><strong>Implications for nursing practice: </strong>Nurses participate in delivering education for patients receiving ICI therapy and their caregivers. Integrating written, visual, and audio materials into existing information pathways may support diverse comprehension levels. Educational efforts should actively involve caregivers and prioritise simplicity and repeated access to information.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"152207"},"PeriodicalIF":2.3,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147516612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}